As of Apr 24
| -0.12 / -1.19%|
The 5 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +100.60% increase from the last price of 9.97.
The current consensus among 5 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.